Osteoglycin (OGN) Inhibits Cell Proliferation and Invasiveness in Breast Cancer via PI3K/Akt/mTOR Signaling Pathway

INTRODUCTION: Previous studies have indicated that the small leucine-rich proteoglycan (SLR) osteoglycin (OGN) is downregulated in various cancers, including squamous cervical carcinoma, gastric cancer, and colorectal adenoma, indicating that OGN is a putative tumor suppressor. However, its exact ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Tao, Zhang, Rui, Dong, Menglu, Zhang, Zeyu, Li, Hanning, Zhan, Chenao, Li, Xingrui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900314/
https://www.ncbi.nlm.nih.gov/pubmed/31824171
http://dx.doi.org/10.2147/OTT.S222967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900314/
https://www.ncbi.nlm.nih.gov/pubmed/31824171
http://dx.doi.org/10.2147/OTT.S222967

Ejemplares similares